SCHEMBL5500541

SCHEMBL5500541

NS(=O)(=O)Cc1ncc(CO)c(CO)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDXK O00764 3/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 1/20 0.49
LMNA P02545 3/20 0.41
CA1 P00915 4/20 0.38
CA2 P00918 4/20 0.38
CA9 Q16790 4/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
AOX1 Q06278 1/20 0.37
TRIM24 O15164 1/20 0.36
TRIM33 Q9UPN9 1/20 0.36
CA12 O43570 1/20 0.34
CA3 P07451 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
MAOB P27338 1/20 0.34
CA5A P35218 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL10628805 0.81 LMNA (0.49) PDXKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL29638818 0.79 PDXK (0.62) PDXKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL3761208 0.79 PDXK (0.62) PDXKKDM4EALDH1A1HPGDHSD17B10
Hydrochloric Acid SCHEMBL11700751 0.77 ALDH1A1 (0.60) PDXKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL2909398 0.74 PDXK (0.61) PDXKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4016022 0.74 KDM4E (0.61) PDXKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL1645737 0.74 PDXK (0.56) PDXKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL3900653 0.72 PDXK (0.50) PDXKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4558720 0.70 PDXK (0.51) PDXKKDM4EALDH1A1HPGDHSD17B10
SCHEMBL11449347 0.70 KDM4E (0.56) PDXKKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142270-A1 Aryl Sulfonic Pyridoxines as Antiplatelet Agents HAQUE WASIMUL 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142270-A1 Aryl Sulfonic Pyridoxines as Antiplatelet Agents PNPO, PRSS1, ARSA PDXK 8/4885KDM4E 3673/4885ALDH1A1 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.